Bader P - Search Results

1

Challenges and opportunities for international cooperative studies in pediatric hematopoeitic cell transplantation: priorities of the Westhafen Intercontinental Group.

Schultz RK, Baker KS, Boelens JJ, Bollard CM, Egeler RM, Cowan M, Ladenstein R, Lankester A, Locatelli F, Lawitschka A, Levine JE, Loh M, Nemecek E, Niemeyer C, Prasad VK, Rocha V, Shenoy S, Strahm B, Veys P, Wall D, Bader P, Grupp SA, Pulsipher MA, Peters C. Schultz RK, et al. Among authors: bader p. Biol Blood Marrow Transplant. 2013 Sep;19(9):1279-87. doi: 10.1016/j.bbmt.2013.07.006. Epub 2013 Jul 21. Biol Blood Marrow Transplant. 2013. PMID: 23883618 Free PMC article.

2

Serial and quantitative analysis of mixed hematopoietic chimerism by PCR in patients with acute leukemias allows the prediction of relapse after allogeneic BMT.

Bader P, Beck J, Frey A, Schlegel PG, Hebarth H, Handgretinger R, Einsele H, Niemeyer C, Benda N, Faul C, Kanz L, Niethammer D, Klingebiel T. Bader P, et al. Bone Marrow Transplant. 1998 Mar;21(5):487-95. doi: 10.1038/sj.bmt.1701119. Bone Marrow Transplant. 1998. PMID: 9535041 Clinical Trial.

3

Megadose transplantation of purified peripheral blood CD34(+) progenitor cells from HLA-mismatched parental donors in children.

Handgretinger R, Klingebiel T, Lang P, Schumm M, Neu S, Geiselhart A, Bader P, Schlegel PG, Greil J, Stachel D, Herzog RJ, Niethammer D. Handgretinger R, et al. Among authors: bader p. Bone Marrow Transplant. 2001 Apr;27(8):777-83. doi: 10.1038/sj.bmt.1702996. Bone Marrow Transplant. 2001. PMID: 11477433 Clinical Trial.

4

Transplantation of highly purified CD34+ progenitor cells from unrelated donors in pediatric leukemia.

Lang P, Handgretinger R, Niethammer D, Schlegel PG, Schumm M, Greil J, Bader P, Engel C, Scheel-Walter H, Eyrich M, Klingebiel T. Lang P, et al. Among authors: bader p. Blood. 2003 Feb 15;101(4):1630-6. doi: 10.1182/blood-2002-04-1203. Epub 2002 Oct 10. Blood. 2003. PMID: 12393439 Free article.

5

Minimal residual disease prior to stem cell transplant for childhood acute lymphoblastic leukaemia.

Goulden N, Bader P, Van Der Velden V, Moppett J, Schilham M, Masden HO, Krejci O, Kreyenberg H, Lankester A, Révész T, Klingebiel T, Van Dongen J. Goulden N, et al. Among authors: bader p. Br J Haematol. 2003 Jul;122(1):24-9. doi: 10.1046/j.1365-2141.2003.04394.x. Br J Haematol. 2003. PMID: 12823342 Free article. Review.

6

A prospective comparison of immune reconstitution in pediatric recipients of positively selected CD34+ peripheral blood stem cells from unrelated donors vs recipients of unmanipulated bone marrow from related donors.

Eyrich M, Leiler C, Lang P, Schilbach K, Schumm M, Bader P, Greil J, Klingebiel T, Handgretinger R, Niethammer D, Schlegel PG. Eyrich M, et al. Among authors: bader p. Bone Marrow Transplant. 2003 Aug;32(4):379-90. doi: 10.1038/sj.bmt.1704158. Bone Marrow Transplant. 2003. PMID: 12900774

7

Level of minimal residual disease prior to haematopoietic stem cell transplantation predicts prognosis in paediatric patients with acute lymphoblastic leukaemia: a report of the Pre-BMT MRD Study Group.

Krejci O, van der Velden VH, Bader P, Kreyenberg H, Goulden N, Hancock J, Schilham MW, Lankester A, Révész T, Klingebiel T, van Dongen JJ. Krejci O, et al. Among authors: bader p. Bone Marrow Transplant. 2003 Oct;32(8):849-51. doi: 10.1038/sj.bmt.1704241. Bone Marrow Transplant. 2003. PMID: 14520434 No abstract available.

8

Clinical relevance of serial quantitative analysis of hematopoietic chimerism after allogeneic stem cell transplantation in children for severe aplastic anemia.

Hoelle W, Beck JF, Dueckers G, Kreyenberg H, Lang P, Gruhn B, Führer M, Niethammer D, Klingebiel T, Bader P. Hoelle W, et al. Among authors: bader p. Bone Marrow Transplant. 2004 Jan;33(2):219-23. doi: 10.1038/sj.bmt.1704337. Bone Marrow Transplant. 2004. PMID: 14647253

9

Transplantation of highly purified peripheral-blood CD34+ progenitor cells from related and unrelated donors in children with nonmalignant diseases.

Lang P, Klingebiel T, Bader P, Greil J, Schumm M, Schlegel PG, Eyrich M, Mueller-Weihrich S, Niethammer D, Handgretinger R. Lang P, et al. Among authors: bader p. Bone Marrow Transplant. 2004 Jan;33(1):25-32. doi: 10.1038/sj.bmt.1704303. Bone Marrow Transplant. 2004. PMID: 14704654 Clinical Trial.

10

Increasing mixed chimerism defines a high-risk group of childhood acute myelogenous leukemia patients after allogeneic stem cell transplantation where pre-emptive immunotherapy may be effective.

Bader P, Kreyenberg H, Hoelle W, Dueckers G, Kremens B, Dilloo D, Sykora KW, Niemeyer C, Reinhardt D, Vormoor J, Gruhn B, Lang P, Greil J, Handgretinger R, Niethammer D, Klingebiel T, Beck JF. Bader P, et al. Bone Marrow Transplant. 2004 Apr;33(8):815-21. doi: 10.1038/sj.bmt.1704444. Bone Marrow Transplant. 2004. PMID: 14990984 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

580 results

Search Page